Related Experiment Video

Updated: Jul 2, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
09:41

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

Published on: June 17, 2014

Bryostatin 1 modulates beta-catenin subcellular localization and transcription activity through protein kinase D1

Meena Jaggi1, Subhash C Chauhan, Cheng Du

  • 1Cancer Biology Research Center, Department of OBGYN and Basic Biomedical Science, Sanford Research/University of South Dakota, Sanford School of Medicine, University of South Dakota, 1400 West 22nd Street, Sioux Falls, SD 57105, USA. meena.jaggi@usd.edu

Molecular Cancer Therapeutics
|September 4, 2008
PubMed

Insights

Bryostatin 1, a natural product, modulates beta-catenin signaling via protein kinase D1 (PKD1) activation. This novel mechanism affects prostate cancer cell behavior and may improve Bryostatin 1 cancer treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Natural products like Bryostatin 1 are explored for cancer treatment.
  • Bryostatin 1 is a protein kinase D (PKD) modulator with antineoplastic properties.
  • E-cadherin/beta-catenin signaling is crucial for cell integrity and often dysregulated in cancer.

Purpose of the Study:

  • To investigate how Bryostatin 1 affects prostate cancer cells.
  • To elucidate the role of protein kinase D1 (PKD1) in Bryostatin 1's mechanism of action.
  • To understand the modulation of beta-catenin signaling by Bryostatin 1 through PKD1.

Main Methods:

  • Prostate cancer cells were treated with Bryostatin 1.
  • PKD1 activation, beta-catenin translocation, and transcription activity were assessed.
  • Changes in cellular aggregation, proliferation, and E-cadherin/beta-catenin localization were analyzed.

Main Results:

  • Bryostatin 1 activated PKD1, leading to beta-catenin colocalization with PKD1 and Golgi markers.
  • PKD1 activation by Bryostatin 1 reduced nuclear beta-catenin and its transcription activity.
  • Bryostatin 1 altered prostate cancer cell aggregation and proliferation, linked to E-cadherin/beta-catenin redistribution.

Conclusions:

  • Bryostatin 1 modulates beta-catenin signaling specifically through PKD1 activation.
  • This study identifies a novel mechanism for Bryostatin 1's action in cancer.
  • Understanding this pathway could enhance the clinical efficacy of Bryostatin 1 treatments.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...